Enhabit Inc

Enhabit Inc (EHAB) News & Events

$13.800

+0.010 (+0.07%)At close

EHAB News

EHAB Events

5/13 10:00

CMS Implements Six-Month Moratorium on New Medicare Enrollment

The Centers for Medicare & Medicaid Services announced it is "taking decisive action to protect Medicare beneficiaries and taxpayer dollars" through implementation of a six-month, nationwide data-driven moratoria on new Medicare enrollment for hospices and home health agencies. "The moratoria will allow CMS to temporarily halt the influx of new providers into these high-risk categories-a key source of fraudulent activity. Today's move continues the Trump Administration's crackdown on fraud, waste, and abuse in the Medicare program by stopping improper billing and preventing bad actors from entering the system," CMS stated. Publicly traded hospice and home health agency operators include Amedisys (AMED), Enhabit (EHAB), Addus HomeCare (ADUS), Pennant Group (PNTG), BrightSpring Health (BTSG) Aveanna (AVAH) and Ensign Group (ENSG).

3/5 18:50

TD Cowen Downgrades Enhabit to Hold with $13.80 Price Target

TD Cowen downgraded Enhabit to Hold from Buy with a $13.80 price target following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.

3/4 16:30

Enhabit Reports Q4 Revenue of $270.4M

Reports Q4 revenue $270.4M, consensus $270.6M. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." As previously announced on Feb. 23, 2026, Enhabit has entered into the Merger Agreement to be acquired by Kinderhook, a middle-market private equity firm, for $13.80 per share in cash, or a total enterprise value of approximately $1.1 billion. The Merger is expected to close in the second quarter of 2026, subject to stockholder approval and other customary closing conditions.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started